Advertisement
Advertisement
BLFS
BioLife Solutions Inc.
24.10
USDSponsored
+0.10
+0.42%
May 21, 12:37 UTC -4
Open
BLFS Earnings Reports
Positive Surprise Ratio
BLFS beat 23 of 42 last estimates.
55%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$28.13M
/$0.03
Implied change from Q1 26 (Revenue/ EPS)
+2.29%
/+50.00%
Implied change from Q2 25 (Revenue/ EPS)
+10.66%
/-400.00%
BioLife Solutions Inc. earnings per share and revenue
On May 07, 2026, BLFS reported earnings of 0.02 USD per share (EPS) for Q1 26, missing the estimate of 0.02 USD, resulting in a -1.96% surprise. Revenue reached 27.50 million, compared to an expected 26.18 million, with a 5.05% difference. The market reacted with a -4.67% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 28.13 million USD, implying an increase of 50.00% EPS, and increase of 2.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.24
Surprise
+41.90%
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.18
Surprise
+6.98%
Valneva SE - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.18
Surprise
-154.60%
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
FitLife Brands, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.12
Actual
$0.17
Surprise
+33.33%
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
$0.21
Surprise
-
Veru Inc.
Report Date
May 13, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.12
Surprise
+58.72%
Bonk, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.23
Surprise
-
Cellectar Biosciences INC NEW
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.92
Actual
-$1.30
Surprise
+32.39%
Innovative Eyewear, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.37
Surprise
+22.82%
FAQ
What were BioLife Solutions Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, BioLife Solutions Inc. reported EPS of $0.02, missing estimates by -1.96%, and revenue of $27.50M, 5.05% above expectations.
How did the market react to BioLife Solutions Inc.'s Q1 2026 earnings?
The stock price moved down -4.67%, changed from $23.12 before the earnings release to $22.04 the day after.
When is BioLife Solutions Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for BioLife Solutions Inc.'s next earnings report?
Based on 9
analysts, BioLife Solutions Inc. is expected to report EPS of $0.03 and revenue of $28.13M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement